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Summary: A recently developed chemiluminescence immunoassay system (LIA-mat) for triiodothyronine and
thyroxine, set up by Byk-Sangtec Diagnostica (Dietzenbach, Germany), has been evaluated and compared
with radioimmunoassays and with a chemiluminescence enhanced enzyme immunoassay (Amerlite), using
control materials circulated in a national interlaboratory quality control, as well as patient sera. The LIA-
mat assays are competitive methods which use coated monoclonal antibodies and triiodothyronine- or
thyroxine-ABEI (aminobutylethylisoluminol) conjugate as tracers. The working range of LIA-mat T3 (com-
puted from the within-assay precision profile) extended from 1.4 to 12.3 nmol/1; the between-assay precision
was 8.1 — 19.3 CV%. Regression analysis of the LIA-mat T3 results (y) against the consensus means (x) of
the participants in the national interlaboratory survey yielded: y = — 0.14 + 1.05 x, r = 0.95. The working
range of LIA-mat T4 extended from 33 to 515 nmol/1; the between-assay precision was 5.4 — 9.2 CV%. An
excellent agreement was found between LIA-mat T4 results (y) and the consensus means (x) of the laboratories
participating in the national interlaboratory survey (y = 3.79 + 1.02 x, r = 0.98).
Introduction , , . . , *with an isolummol derivative as tracers, and a bound/
Thyroxine (T4) and triiodothyronine (T3), two of the free separation method with coated tube technology,
most routinely assayed hormones in the clinical lab- We report here a methodological evaluation of LIA-
oratories, are generally measured by radioimmunoas- mat based on the results from control materials cir-
say (RIA). Although these techniques are fast and culated in a national interlaboratory survey and from
easy to perform and exhibit good precision and ac- patient sera. A comparison with RIA methods and
curacy, they pose some problems mainly related with with a chemiluminescence enhanced enzyme immu-
the short shelf-life of the tracers and the high costs noassay (Amerlite) was also carried out.
of disposal of radioactive waste. Consequently some
non-isotopic immunoassays, using enzymes, fluores-
cent dyes or chemiluminescent compounds as labels, Materials and Methods
have been developed and are now commercially avail-
, , ,. -, Analyt ical procedures
The LIA-mat T4 and LIA-mat T3 are non-isotopic, competitive
Recently a new competitive luminescent assay for immunoassays based on chemiluminescence. T4 or T3 tracer (T4
triiodothyronine and thyroxine (LIA-mat) was devel- or T3 conjugated with aminobutylethylisoluminol - ABEI -
J 1 T ^ 1 0 _^. . _. , . and purified by HPLC) competes with the hormone present mopped by Byk-Sangtec Diagnostica, Dietzenbach the samples for the binding sites of a specific monodonal
FRG; this technique employs T3 and T4 conjugated antibody (anti-T4 or anti-T3) coated on tubes.
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Patient sample (50 μΐ for T4 and 100 μΐ for T3) is incubated at
room temperature in the coated tube with 200 μΐ of tracer, on
a shaker; the incubation time is 2 h for thyroxine and 3 h for
triiodothyronine. After incubation, the supernatant is aspirated
and the test tubes are washed three times with 2 ml of distilled
water. Test tubes containing the bound fraction of the label are
measured by an automatic luminometer (AutoCliniLumat,
Berthold L B912). The chemiluminescence reaction is initiated
by the automated injection into the luminometer of alkaline
hydrogen peroxide in the presence of microperoxidase. Photon
output is accumulated during 5 s and expressed as RLU (rela-
tive light units). The conversion of the measured RLUs (ana-
lytical response) into thyroxine or triiodothyronine concentra-
tion is performed automatically through spline interpolation of
the dose-response curve (with 7 calibrators for thyroxine and
6 calibrators for triiodothyronine) which are carried out in each
run.
To evaluate the performance of the LIA-mat technique, 8 thy-
roxine assays and 10 triiodothyronine assays were carried out;
both calibrators and samples were assayed in duplicate.
Control material and samples
Lyphochek immunoassay control sera (BioRad Laboratories,
Italy) and the control material included in the LIA-mat kits
were used in each assay to estimate the between-assay precision.
The accuracy of the results of the LIA-mat technique were
compared with those of other immunoassays by assaying con-
trol materials previously circulated in the national interlabo-
ratory quality control (QC) for immunoassays, which was or-
ganized by us and supported by National Research Council,
CNR (4). These QC materials consisted of 51 pools which were
distributed on 1 — 5 occasions during the period 1986 — 1988 to
about 200 laboratories. The method/kits used by the partici-
pants in the interlaboratory survey were mostly radioimmu-
noassays (> 90%). The consensus means of the results reported
by all participants in the QC survey were assumed as reference
values and compared with the determinations produced by LIA-
mat.
Moreover, samples from normal, hypo- and hyper-thyroid pa-
tients, previously determined in our laboratory using RIA Spac
and Amerlite, were assayed by LIA-mat to compare the per-
formances of these three methods. RIA Spac (technique devel-
oped by Byk-Sangtec Diagnostica, and very similar to LIA-
mat except for the tracer) and Amerlite (chemiluminescence
enhanced enzyme immunoassay (5), produced by Amersham




The reproducibility of the analytical response (RLU)
of thyroxine and triiodothyronine assays was evalu-
ated from all duplicates (both of the calibrators and
of the unknown samples); figure 1 shows the mean
CV of all the duplicates subdivided into 5 response
intervals (both for T3 and for T4 assay). We found
that the CV of the response for LIA-mat T4 was 3.8%
on average; the precision of the response of LIA-mat
T3 was worse (5.2 CV% on average). In both assays
the CV of the response was found to be approximately
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Fig. 1. Variability of the analytical response (relative light
units) of LIA-mat T4 and LIA-mat T3. Response (ab-
scissa) is reported both as RLU and as B/B0; corre-
sponding triiodothyronine or thyroxine concentrations
are also indicated.
Estimation of the precision profile
The mean precision profiles (6) were computed from data of
all the assays, using a previously described computer program
(7). In particular the response variability was modelled by a
RER (response error relationship) of the type: Var (R) = KiR
+ K2R2, and the two parameters (Kl5 K2) were determined
using all duplicates (standards and samples) of the assays (8).
The sensitivity (lowest detection limit) is read on the precision
profile as the lowest concentration distinguishable from zero
(confidence limit ± 2 SD) or concentration corresponding to
50% CV. The working range was also derived from trie precision
profile, as the concentration range measurable with a within-
assay precision better than 10% CV.
The mean dose-response curves are depicted in figure
2; when expressed as B/B0 they are very similar to the
calibration curves of the methods RIA Spac T3 and
T4.
Starting from the variability of the response and the
slope of the dose-response curve, the precision profiles
of the T4 and T3 LIA-mat were computed; figure 2
reports the mean precision profiles of LIA-mat com-
pared with those for the RIA Spac technique. We
found that, as far as thyroxine assay is concerned, the
within-assay precision of the luminescent and isotopic
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Fig. 2. Mean precision profiles for LIA-mat T3 and LIA-mat
T4 (closed squares); precision profiles of RIA Spac T3
and T4 (closed circles) are reported for comparison.
Typical dose-response curves of LIA-mat T3 and LIA-
mat T4 (closed squares) are also depicted in the inset
figures.
The sensitivity is read on the precision profile as the
lowest concentration distinguishable from zero (confi-
dence limit 2 SD) or concentration corresponding to
50% CV; the lower limit of the working range is read
as the lower concentration measurable with a within-
assay precision better than 10% CV (dashed lines). The
following values were found:
Triiodothyronine Thyroxine
nmol/l nmol/l
LIA- RIA LIA- RIA
mat Spac mat Spac
Sensitivity










systems are very similar (LIA-mat T4: sensitivity 5.3
nmol/l, lower limit of the working range 33 nmol/l;
RIA-Spac T4: sensitivity 6.6 nmol/l, lower limit of the
working range 27 nmol/l). On the other hand, the
within-assay precision of LIA-mat T3 was somewhat
worse than that of RIA Spac (LIA-mat T3: sensitivity
0.23 nmol/l, lower limit of the working range 1.4
nmol/l; RIA Spac T3: sensitivity 0.18 nmol/l, lower
limit of the working range 0.97 nmol/l); in particular
the relatively high CV in the range 1.1 — 1.3 nmol/l
makes it difficult to differentiate between hypothyroid
and low normal triiodothyronine values.
Data on the between-assay precision of the LIA-mat
T3 and T4 are reported in table 1; it can be seen that
the precision of the thyroxine assay is better (CV
range: 5.4 — 9.2%, except for the low concentration
QC sample) than that of the triiodothyronine assay
(CV range: 8.1 — 19.3%, except for the low concen-
tration QC sample). This finding partially reflects the
poorer within-assay precision of the triiodothyronine
assay.
2 Accuracy
Results of regression analysis of LIA-mat triiodo-
thyronine and thyroxine determinations against the
consensus means of the interlaboratory survey in
about 100 QC samples derived from 51 pools (most
of which were sent on more than one occasion as
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Regression analysis of LIA-mat T3 results (upper panel:
y = -0.14 + 1-05x, r = 0.95, n = 101) and LIA-mat
T4 results (lower panel: y = 3.79 + 1.02x, r = 0.98,
n = 89) against the respective consensus means from
the interlaboratory survey, assumed as reference values.
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Tab. 1. Between-assay precision of T3 and T4 LIA-mat
Triiodothyronine, nmol/1 Thyroxine, nmol/1
SD cv% χ ± SD
L = Lyphochek control serum
CK = control material included in the kit






















































It is evident that both triiodothyronine and thyroxine
LIA-mat systems produce results in good agreement
with the consensus means assumed as reference values.
The lower value of the regression coefficient observed
for the triiodothyronine assay is attributable to the
poorer between-assay precision in respect to that ob-
served for thyroxine.
The LIA-mat results were compared with those ob-
tained by RIA Spac T3 and T4 methods by assaying
about 100 samples from normals and patients; the
regression analysis, reported in table 2, indicates a
good agreement between the two techniques.
Tab. 2. Regression analysis of LIA-mat (y) against RIA Spac
(x) results
Triiodothyronine,
concentration range 0.8—4.2 nmol/1 (n = 95*)
y = -0.08 + 1.04 χ nmol/1; r = 0.82
Thyroxine,
concentration range 6.4 — 270 nmol/1 (n = 111*)
y = 8.9 + 0.92 χ nmol/1; r = 0.95
* samples from eu-, hypo- and hyperthyroid patients
The system LIA-mat was also compared with another
luminescent technique (the system Amerlite set up by
Amersham International) by assaying samples from
normals and patients. The results of the two techni-
ques, reported in figure 4, were in good agreement.
In conclusion, the LIA-mat technique for the deter-
mination of triiodothyronine and thyroxine shows
analytical reliability similar to that of RIA methods.
It is fast and easy to be performed and therefore
represents a suitable alternative to the traditional iso-
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Fig. 4. Regression analysis of LIA-mat T3 results (upper panel:
y = 0.20 + 0.98 x, r = 0.93, n = 37) and LIA-mat T4
results (lower panel: y = 8.51 + 0.93 x, r = 0.97,
n = 45) against the determinations produced by a chemi-
luminescence enhanced enzyme immunoassay (Amer-
lite) in samples from normals and patients.
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